{
    "id": "5c0e838b133db5eb7800002e",
    "question": "Is obesity related to cognitive decline?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, let's consider the relevant information provided in the documents. Document 9 (Title: Obstentrics_Williams) discusses the consequences of obesity, which include glucose intolerance, hypertension, dyslipidemia, and metabolic syndrome. These conditions are associated with cognitive decline and can lead to neurodegeneration. Document 19 (Title: Pharmacology_Katzung) mentions that obesity is a risk factor for various diseases, including cardiovascular and neurodegenerative diseases. Document 21 (Title: InternalMed_Harrison) states that diabetes, which is often associated with obesity, affects all four main aging systems that contribute to frailty and can lead to cognitive decline. Furthermore, Document 9 (Title: Obstentrics_Williams) suggests that metabolic syndrome, which is closely linked to obesity, causes structural cerebral changes and lower executive functioning and memory in adults. Document 22 (Title: Neurology_Adams) reports that a higher than average glucose level over the preceding 5 years conferred a slightly increased risk of dementia, but the ostensible mechanism by which this confers risk (if it is even valid) has not been established. Given this information, it appears that obesity is related to cognitive decline, as it is associated with various conditions that can lead to neurodegeneration and cognitive impairment. Therefore, the correct answer is A. yes.\", \"answer_choice\": \"A\"}",
    "snippets": [
        {
            "id": "InternalMed_Harrison_834",
            "title": "InternalMed_Harrison",
            "content": "CRP and IL-6. Altered signaling can affect neurode generation; insulin resistance and adipokines such as leptin and adiponectin are associated with declines in but these findings are not specific and their diagnostic utility is unclear (Fig. 11-15). Other neurophysiologic changes in the brain frequently occur with aging and may contribute to cognitive decline. Functional imaging studies have shown that some older people have diminished coordination between the brain regions responsible for higher-order cognitive functions and that such diminished coordination is correlated with poor cognitive performance. In young healthy individuals, the brain activity associated with executive cognitive functions (e.g., problem-solving, decision-making) is very well localized; in contrast, in healthy older individuals, the pattern of cortical activation is more diffuse. Brain pathology has typically been associated with specific diseases; amyloid plaques and neurofibrillary tangles are considered"
        },
        {
            "id": "InternalMed_Harrison_829",
            "title": "InternalMed_Harrison",
            "content": "Neurodegeneration It was long generally believed that neurons stop reproducing shortly after birth and that their number declines throughout life. However, results from animal models and even some studies in humans suggest that neurogenesis in the hippocampus continues at low levels throughout life. Brain atrophy occurs with aging after the age of 60 years. Atrophy proceeds at varying rates in different parts of the brain (Fig. 11-14) and is often accompanied by an inflammatory response and microglial activation. Age-associated brain atrophy may contribute to age-related declines in cognitive and motor function. Atrophy may also be a factor in some brain diseases that can occur with aging, such as mild cognitive impairment, in which persons have mild but detectable impairments on tests of cognition but no severe disability in daily activities. In mild cognitive impairment, atrophy has been found mostly in the prefrontal cortex and hippocampus, develop a mild proinflammatory state"
        },
        {
            "id": "InternalMed_Harrison_19503",
            "title": "InternalMed_Harrison",
            "content": "Hypertension also is associated with impaired cognition in an aging population, and longitudinal studies support an association between midlife hypertension and late-life cognitive decline. Hypertension-related cognitive impairment and dementia may be a consequence of a single infarct due to occlusion of a \u201cstrategic\u201d larger vessel or multiple lacunar infarcts due to occlusive small vessel disease resulting in subcortical white matter ischemia. Several clinical trials suggest that antihypertensive therapy has a beneficial effect on cognitive function, although this remains an active area of investigation."
        },
        {
            "id": "InternalMed_Harrison_836",
            "title": "InternalMed_Harrison",
            "content": "Taken together, trends in brain changes with aging suggest that some neurophysiologic manifestations are compensatory adaptations rather than primary contributors to age-related declines. Because the brain is capable of reorganization and compensation, extensive neurodegeneration may not be clinically evident. Therefore, early detection requires careful testing. Clinically, cortical and subcortical changes are reflected in the high prevalence of \u201csoft,\u201d nonspecific neurologic signs, often reflected in slow and unstable gait, poor balance, and slow reaction times. These movement changes can be elicited more overtly with \u201cdual tasks,\u201d in which a 1050 cognitive function. Combined with loss of motor neurons and dysfunction of the motor unit, a state of inflammation and reduced levels of testosterone and IGF-1 have been linked to accelerated decline of muscle mass and strength. Normal intersystem coordination is also affected by aging. The hypothalamus normally functions as a central"
        },
        {
            "id": "Neurology_Adams_3414",
            "title": "Neurology_Adams",
            "content": "In most studies, 10 to 20 percent per year of such affected patients with mild cognitive decline will be found to have later acquired Alzheimer disease. A number of factors have been identified as associated with a progression to a state of indisputable dementia. These include elevated blood pressure, changes in the cerebral white matter on MRI, abnormality of gait, and\u2014perhaps not surprisingly\u2014certain biologic markers that are connected to Alzheimer disease. Other factors for the development of dementia, particularly the level of prior education and maintenance of an active mental life, have been studied in relation to the later development of Alzheimer disease, much of which has reached the popular consciousness in diluted form, and are discussed in Chap. 38."
        },
        {
            "id": "Neurology_Adams_3411",
            "title": "Neurology_Adams",
            "content": "It has become apparent that many individuals have memory complaints that are mild and do not interfere with daily functioning but are still disproportionate for the patient\u2019s age and education. It is often difficult to differentiate this very troubling but less-intrusive problem, which may be a result of the normal process of aging, from dementia. The condition has been called mild cognitive impairment, and in the past, age-associated memory impairment, or benign senescent forgetfulness, as discussed in Chap. 28. When other aspects of mental functioning are affected, terms such as aging-associated cognitive decline had been used. Defining the boundaries of such a condition has proved problematic, and determining the risk of progression to a dementing illness that does interfere with daily function, even more so. There is a further problem introduced by the premise that highly intelligent individuals would have to decline considerably on intelligence and memory tests to be identified"
        },
        {
            "id": "Psichiatry_DSM-5_2915",
            "title": "Psichiatry_DSM-5",
            "content": "When cognitive loss occurs in youth to midlife, individuals and families are likely to seek care. NCDs are typically easiest to identify at younger ages, although in some settings malingering or other factitious disorders may be a concern. Very late in life, cognitive symptoms may not cause concern or may go unnoticed. In late life, mild NCD must also be distinguished from the more modest deficits associated with \u201cnormal aging,\u201d although a substantial fraction of what has been ascribed to normal aging likely represents prodromal phases of various NCDs. In addition, it becomes harder to recognize mild NCD with age because of the increasing prevalence of medical illness and sensory deficits. It becomes harder to differentiate among subtypes with age because there are multiple potential sources of neurocognitive decline."
        },
        {
            "id": "InternalMed_Harrison_27570",
            "title": "InternalMed_Harrison",
            "content": "coGnitive decline and dementia A meta-analysis of 10 case-control and two cohort studies suggested that postmenopausal HT is associated with a 34% decreased risk of dementia. Subsequent randomized trials (including the WHI), however, have failed to demonstrate any benefit 2386 of estrogen or estrogen-progestin therapy on the progression of mild to moderate Alzheimer\u2019s disease and/or have indicated a potential adverse effect of HT on the incidence of dementia, at least in women \u226565 years of age. Among women randomized to HT (as opposed to placebo) at age 50\u201355 in the WHI, no effect on cognition was observed during the postintervention phase. Determining whether timing of initiation of HT influences cognitive outcomes will require further study."
        },
        {
            "id": "Neurology_Adams_8440",
            "title": "Neurology_Adams",
            "content": "Several putative epidemiologic risk factors for Alzheimer disease proposed in the past, such as birth order, mother\u2019s age at birth, and a family history of Down syndrome seem marginal at best and in some instances, may be a result of selection bias. Depression and possibly head injuries seem to confer a somewhat increased risk later in life. Whether low educational attainment is a risk factor for the development of Alzheimer disease or, conversely, whether cognitively demanding occupations or higher intelligence protects against dementia is still under discussion. Provocative data indicating that inherent intellectual endowment (cognitive reserve) is important were presented in Chap. 20 (Katzman; Cobb et al). Finally, associations between diabetes or hyperglycemia and dementia, in general, have emerged from epidemiologic studies, for example, one reported by Crane and coworkers, but the ostensible mechanism by which this confers risk (if it is even valid) has not been established. In"
        },
        {
            "id": "Obstentrics_Williams_6601",
            "title": "Obstentrics_Williams",
            "content": "Obese individuals sufer well-known consequences such as glucose intolerance, hypertension, dyslipidemia, and metabolic syndrome. Furthermore, metabolic syndrome and obesity are linked with cardiovascular disease, including myocardial infarction, atrial ibrillation, heart failure, and stroke (Long, 2016). Insulin resistance and metabolic syndrome cause structural cerebral changes and lower executive functioning and memory in adults. Similar consequences are also found in adolescents, suggesting that metabolic syndrome's efects on neurocognitive function are independent of signiicant occlusive vascular disease (Rusinek, 2014)."
        },
        {
            "id": "Neurology_Adams_4750",
            "title": "Neurology_Adams",
            "content": "Kral, who first wrote informatively on this type of memory disturbance 50 years ago, referred to it as benign senescent forgetfulness. He pointed out that such a memory disturbance, in distinction to that of Alzheimer disease, worsens very little or not at all over a period of many years and does not interfere significantly with the person\u2019s work performance or activities of daily living. Crook and coworkers have refined the diagnostic criteria for senescent forgetfulness and proposed the term age-associated memory impairment (AAMI). The diagnostic criteria for AAMI include age of 50 years or older, a subjective sense of decline in memory, impaired performance on standard tests of memory function (at least one SD below the mean), and absence of any other signs of dementia. The current terminology is minimal cognitive impairment, but there has been increasing recognition that Kral\u2019s original notion of a benign condition may have been incorrect and that cognitive decline in later years"
        },
        {
            "id": "Neurology_Adams_4753",
            "title": "Neurology_Adams",
            "content": "associates of a large urban population indicates a median score of 19 to 20 for individuals older than age 80 years who have a fourth grade education and 27 for those with a college education (out of maximum score of 30). A similar Montreal Cognitive Assessment has become popular in recent years (MOCA, range 0 to 30 with higher scores being better). Many other scales have been devised that detect cognitive decline with age, most conceived for the purpose of clinical trials, but they do not find much use in daily practice."
        },
        {
            "id": "Neurology_Adams_4751",
            "title": "Neurology_Adams",
            "content": "is minimal cognitive impairment, but there has been increasing recognition that Kral\u2019s original notion of a benign condition may have been incorrect and that cognitive decline in later years may be a premonitory symptom of Alzheimer disease."
        },
        {
            "id": "Neurology_Adams_8493",
            "title": "Neurology_Adams",
            "content": "of \u201ccognitive reserve\u201d having either a protective property or simply hiding mental decline, has emerged from numerous other studies. Also, there has been a general perception, confirmed by a few studies such as the one by Verghese and colleagues, that an active mental life may reduce the severity of mental decline with aging, but firm conclusions about causation cannot be made from the available information."
        },
        {
            "id": "Neurology_Adams_4746",
            "title": "Neurology_Adams",
            "content": "Effects of Aging on Memory and Other Cognitive Functions Probably the most detailed information as to the effects of age on the nervous system comes from the measurement of cognitive functions. In the course of standardization of the original Wechsler-Bellevue Intelligence Scale (1955), cross-sectional studies of large samples of the population indicated that there was a steady decline in cognitive function starting at 30 years of age and progressing into old age. Apparently all forms of cognitive function partake of this decline\u2014although in general certain elements of the verbal scale (vocabulary, fund of information, and comprehension) withstand the effects of aging better than those of the performance scale (block design, reversal of digits, picture arrangement, object assembly, and the digit symbol task)."
        },
        {
            "id": "Neurology_Adams_4772",
            "title": "Neurology_Adams",
            "content": "As described earlier in normal aging, there is a gradual decline in memory and in some cognitive functions. In light of the studies just summarized, it is no longer considered that these changes can be ascribed simply to neuronal loss. Rather, they are probably caused, at least in part, by alterations in synaptic connectivity within critical cortical structures."
        },
        {
            "id": "Neurology_Adams_4747",
            "title": "Neurology_Adams",
            "content": "However, the concept of a linear regression of cognitive function with aging has had to be modified in the light of subsequent longitudinal studies. If the same individual is examined over a period of many years, there is virtually no decline in performance, as measured by tests of verbal function, until about 60 years of age. Beyond this age, verbal intelligence does decline, but very slowly\u2014by an average of less than 5 percent through the seventh decade and by less than 10 percent through the eighth decade (Schaie and Hertzog). Also, in a series of 460 community-dwelling individuals (55 to 95 years of age) studied by Smith and coworkers (1992), there was no significant decline with age in verbal memory and in registration\u2013attention; similar results were found by Petersen and colleagues in 161 normal, community-dwelling individuals 62 to 100 years of age. The most definite effects of age were in learning and memory and in problem solving\u2014cognitive impairments probably attributable to"
        },
        {
            "id": "InternalMed_Harrison_823",
            "title": "InternalMed_Harrison",
            "content": "MRI, fMRI, PET, and other dynamic imaging techniques aMini Mental State; Montreal Cognitive Assessment. Abbreviations: BMI, body mass index; CRP, C-reactive protein; DEXA, dual-energy x-ray absorptiometry; ESR, erythrocyte sedimentation rate; fMRI, functional MRI; IL-6, interleukin 6; PET, positron emission tomography; TNF\u03b1, tumor necrosis factor \u03b1. FIgURE 11-8 Longitudinal changes of weight, body composition, and waist circumference over the life span, estimated in 1167 participants in the Baltimore Longitudinal Study of Aging. Lean body mass (LBM) and fat mass were estimated with dual-energy x-ray absorptiometry. (Source: The Baltimore Longitudinal study of Aging 2010; unpublished data.) Survivors, n = 3680 Non-survivors, n = 3680"
        },
        {
            "id": "Neurology_Adams_7837",
            "title": "Neurology_Adams",
            "content": "Certain metabolic diseases may be the cause of serious disturbances of cognitive function and behavior, even in the adolescent and early adult period. The diagnosis and management of these metabolic diseases are so unusual that some special remarks are appropriate. When they present later in adolescence and adult life they evolve more slowly than childhood forms. The most obvious and easily detectable of these derangements are in the cognitive sphere, that is, memory, calculation, problem solving, and verbal skills. Impulsivity, loss of self-control, and antisocial behavior are the most troubling behavioral abnormalities. Each of these phenomena has its own cerebral anatomy, as pointed out in Chap. 21, and the state of dementia comprises various degrees and combinations of these abnormalities."
        },
        {
            "id": "Pharmacology_Katzung_6621",
            "title": "Pharmacology_Katzung",
            "content": "When all confounders are accounted for, age itself is still the strongest risk factor for cardiovascular and neurodegenerative diseases and most forms of cancer. Research into the molecular basis of aging has answered a few questions and opened many more. It has long been known that caloric restriction alone can prolong the life span of animals, including mammals. Some evidence suggests He cannot remember the names of his three adult children or three random words (eg, tree, flag, chair) for more than 2 minutes. No cataracts are visible, but he is unable to read standard newsprint without a powerful magnifier. Why doesn\u2019t he take his antihypertensive medications? What therapeutic measures are available for the treatment of Alzheimer\u2019s disease? How might macular degeneration be treated?"
        },
        {
            "id": "Neurology_Adams_7278",
            "title": "Neurology_Adams",
            "content": "It has become evident that some degree of cognitive impairment, and probably a progressive decline, is present in perhaps one-half of patients with long-standing MS. The process is characterized by reduced attention, diminished processing speed and executive skills, and memory decline, while language skills and other intellectual functions are preserved, features that have been subsumed under \u201csubcortical dementia,\u201d as discussed in Chap. 20. Other mental disturbances, such as a loss of retentive memory, global dementia, or a confusional\u2013psychotic state, also occur in a limited number of cases in the advanced stages of the disease, but we have found this degree of deterioration to be exceptional. The decline in cognitive functions correlates with quantifiable MRI measurements, particularly loss of white matter volume, thinning of the corpus callosum, and brain atrophy (reviewed by Bobholz and Rao)."
        },
        {
            "id": "InternalMed_Harrison_895",
            "title": "InternalMed_Harrison",
            "content": "diabetes (See also Chaps. 417\u2013419) Both the incidence and the prevalence of diabetes mellitus increase with aging. Among persons \u226565 years old, the prevalence is \u223c12% (with higher figures among African Americans and Hispanics), reflecting the effects of population aging and the obesity epidemic. Diabetes affects all four main aging systems that contribute to frailty. Obesity, especially visceral obesity, is a strong risk factor for insulin resistance, the metabolic syndrome, and diabetes. Diabetes is associated with both reduced muscle mass and accelerated rates of muscle wasting. Diabetic patients have an elevated RMR and a poor degree of fitness. Diabetes is associated with multiple hormone dysregulation, a proinflammatory state, and excess oxidative stress. Finally, diabetes-induced neurodegeneration involves both the central and peripheral nervous systems. Given these characteristics, it is not surprising that patients with diabetes mellitus are more likely to be frail and at high"
        },
        {
            "id": "Neurology_Adams_8441",
            "title": "Neurology_Adams",
            "content": "have emerged from epidemiologic studies, for example, one reported by Crane and coworkers, but the ostensible mechanism by which this confers risk (if it is even valid) has not been established. In their report, a higher than average glucose level over the preceding 5 years conferred a slightly increased risk of dementia but not necessarily of Alzheimer disease."
        },
        {
            "id": "InternalMed_Harrison_2014",
            "title": "InternalMed_Harrison",
            "content": "Subtle cumulative decline in episodic memory is a common part of aging. This frustrating experience, often the source of jokes and humor, is referred to as benign forgetfulness of the elderly. Benign means that it is not so progressive or serious that it impairs reasonably successful and productive daily functioning, although the distinction between benign and more significant memory loss can be difficult to make. At age 85, the average person is able to learn and recall approximately one-half of the items (e.g., words on a list) that he or she could at age 18. A measurable cognitive problem that does not seriously disrupt daily activities is often referred to as mild cognitive impairment (MCI). Factors that predict progression from MCI to an AD dementia include a prominent memory deficit, family history of dementia, presence of an apolipoprotein \u03b54 (Apo \u03b54) allele, small hippocampal volumes, an AD-like signature of cortical atrophy, low cerebrospinal fluid A\u03b2, and elevated tau or"
        },
        {
            "id": "InternalMed_Harrison_830",
            "title": "InternalMed_Harrison",
            "content": "of cognition but no severe disability in daily activities. In mild cognitive impairment, atrophy has been found mostly in the prefrontal cortex and hippocampus, develop a mild proinflammatory state characterized by high levels of proinflammatory markers, including interleukin 6 (IL-6) and C-reactive protein (CRP) (Fig. 11-13). Aging is also thought to be associated with increased oxidative stress damage, either because the production of reactive oxygen species increases or because antioxidant buffers are less effective. Since hormones, inflammatory markers, and antioxidants are integrated into complex signaling networks, levels"
        },
        {
            "id": "Psichiatry_DSM-5_2940",
            "title": "Psichiatry_DSM-5",
            "content": "Most individuals with Alzheimer\u2019s disease are elderly and have multiple medical conditions that can complicate diagnosis and in\ufb02uence the clinical course. Major or mild NCD due to Alzheimer\u2019s disease commonly co-occurs with cerebrovascular disease, which contributes to the clinical picture. When a comorbid condition contributes to the NCD in an individual with Alzheimer\u2019s disease, then NCD due to multiple etiologies should be diagnosed. A. The criteria are met for major or mild neurocognitive disorder. B. The disturbance has insidious onset and gradual progression. C. Either (1) or (2): 1. Behavioral variant: a. Three or more of the following behavioral symptoms: i. Behavioraldisinhibition. ii. Apathy or inertia. iii. Loss of sympathy or empathy. v. Perseverative, stereotyped or compulsive/ritualistic behavior. v. Hyperorality and dietary changes. b. Prominent decline in social cognition and/or executive abilities."
        },
        {
            "id": "Psichiatry_DSM-5_2925",
            "title": "Psichiatry_DSM-5",
            "content": "1. Evidence of a causative Alzheimer\u2019s disease genetic mutation from family history or genetic testing. 2. All three of the following are present: a. Clear evidence of decline in memory and learning and at least one other cogni- tive domain (based on detailed history or serial neuropsychological testing). b. Steadily progressive, gradual decline in cognition, without extended plateaus. c. No evidence of mixed etiology (i.e., absence of other neurodegenerative or cerebrovascular disease, or another neurological, mental, or systemic disease or condition likely contributing to cognitive decline). For mild neurocognitive disorder: Probable Alzheimer's disease is diagnosed if there is evidence of a causative Alz- heimer\u2019s disease genetic mutation from either genetic testing or family history."
        },
        {
            "id": "Psichiatry_DSM-5_2926",
            "title": "Psichiatry_DSM-5",
            "content": "For mild neurocognitive disorder: Probable Alzheimer's disease is diagnosed if there is evidence of a causative Alz- heimer\u2019s disease genetic mutation from either genetic testing or family history. Possible Alzheimer's disease is diagnosed if there is no evidence of a causative Alz- heimer\u2019s disease genetic mutation from either genetic testing or family history, and all three of the following are present: 1. Clear evidence of decline in memory and learning. 2. Steadily progressive, gradual decline in cognition, without extended plateaus. 3. No evidence of mixed etiology (i.e., absence of other neurodegenerative or cere- brovascular disease, or another neurological or systemic disease or condition likely contributing to cognitive decline). D. The disturbance is not better explained by cerebrovascular disease. another neurode- generative disease, the effects of a substance, or another mental, neurological, or sys- temic disorder."
        },
        {
            "id": "Psichiatry_DSM-5_3044",
            "title": "Psichiatry_DSM-5",
            "content": "(Note: Do not use the additional code for Parkinson\u2019s disease. Behavioral disturbance cannot be coded but should still be indicated in writing.) The essential feature of major or mild neurocognitive disorder (NCD) due to Parkinson\u2019s disease is cognitive decline following the onset of Parkinson\u2019s disease. The disturbance must occur in the setting of established Parkinson\u2019s disease (Criterion B), and deficits must have developed gradually (Criterion C). The NCD is viewed as probably due to Parkinson\u2019s disease when there is no evidence of another disorder that might be contributing to the cognitive decline and when the Parkinson\u2019s disease clearly precedes onset of the NCD. The NCD is considered possibly due to Parkinson\u2019s disease either when there is no evidence of another disorder that might be contributing to the cognitive decline or when the Parkin- son\u2019s disease precedes onset of the NCD, but not both."
        },
        {
            "id": "Neurology_Adams_8435",
            "title": "Neurology_Adams",
            "content": "This is the most common and important degenerative disease of the brain, having an immense societal impact. Some aspects of the intellectual deterioration that characterize this disease were described in Chap. 20, under \u201cThe Neurology of Dementia,\u201d and the still ambiguous relationship of this disease to the aging process is mentioned above and in Chap. 28. There it was pointed out that some degree of shrinkage in size and weight of the brain, that is \u201catrophy,\u201d is an inevitable accompaniment of advancing age, but that these changes alone are of relatively slight clinical significance and uncertain structural basis (e.g., whether the loss of brain weight aging is the result of a simple depletion of neurons). By contrast, severe degrees of diffuse cerebral atrophy that evolve over a few years are associated with dementia, and the underlying pathologic changes in these cases most often prove to be those of Alzheimer disease. As also commented on in Chap. 28, the rate of cerebral atrophy,"
        },
        {
            "id": "InternalMed_Harrison_810",
            "title": "InternalMed_Harrison",
            "content": "Systemic consequences of aging are widespread but can be clustered into four main domains or processes (Fig. 11-7): (1) body composition; (2) balance between energy availability and energy demand; (3) signaling networks that maintain homeostasis; and (4) neurodegeneration. Each domain can be assessed with routine clinical tests, although more detailed research techniques are also available (Table 11-2)."
        },
        {
            "id": "Neurology_Adams_4795",
            "title": "Neurology_Adams",
            "content": "Roos MR, Rice CL, Connelly DM, Vandervoort AA: Quadriceps muscle strength, contractile properties, and motor unit firing rates in young and old men. Muscle Nerve 22:1094, 1999. Roth M, Tomlinson BE, Blessed G: Correlation between scores for dementia and counts of senile plaques in cerebral grey matter of elderly subjects. Nature 209:109, 1966. Rusinek H, De Santi S, Frid D, et al: Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MRI imaging study of normal aging. Radiology 229:691, 2003. Schaie KW, Hertzog C: Fourteen-year cohort-sequential analyses of adult intellectual development. Dev Psychol 19:531, 1983. Scheibel M, Lindsay RD, Tomiyasu U, Scheibel AB: Progressive dendritic changes in aging human cortex. Exp Neurol 47:392, 1975. Small SA, Tsai WY, DeLaPaz R, et al: Imaging hippocampal function across the human life span: Is memory decline normal or not? Ann Neurol 51:290, 2002."
        }
    ],
    "scores": [
        0.038129522891437215,
        0.0342093058966874,
        0.033103140019285514,
        0.0317987827411185,
        0.03079755442666709,
        0.029286283891547048,
        0.028631303144602615,
        0.027828295480967238,
        0.02604997036952075,
        0.02585776060123495,
        0.025786512362335354,
        0.02549212047262428,
        0.02482648930017351,
        0.02473847290920462,
        0.02399575532692416,
        0.023811301966641774,
        0.023319809605295415,
        0.023208380838723196,
        0.02296693657733647,
        0.022454795597484273,
        0.02150746980292435,
        0.021082758251751994,
        0.020185985667159595,
        0.019276123440130806,
        0.018637309292649097,
        0.018067738483446664,
        0.017028985507246377,
        0.016968651136036815,
        0.01690340909090909,
        0.016584766584766583,
        0.01605126253013577,
        0.015662943176299175
    ]
}